Assignee
CELLID CO LTD
KR·1 granted patent·3 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0162US2026091112A1Vaccine comprising peripheral blood mononuclear cells loaded with natural killer t cell ligand and antigenCELLID CO LTD·Filed 2023·Application pending·0 cites
- 0257US2025170179A1Vaccine comprising natural killer cells loaded with ligands of natural killer t cells and cancer antigensCELLID CO LTD·Filed 2023·Application pending·0 cites
- 0349US12098384B2Adenoviral vector not including replication competent adenovirus, and use thereofCELLID CO LTD·Filed 2022·Granted Sep 24, 2024·0 cites·14 claims
- 0437US2023293670A1Novel coronavirus recombinant spike protein, polynucleotide encoding same, vector comprising polynucleotide, and vaccine for preventing or treating coronavirus infection, comprising vectorCELLID CO LTD·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →